These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25037815)

  • 1. Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to anakinra.
    Amazan E; Ezzedine K; Mossalayi MD; Taieb A; Boniface K; Seneschal J
    J Am Acad Dermatol; 2014 Aug; 71(2):e53-6. PubMed ID: 25037815
    [No Abstract]   [Full Text] [Related]  

  • 2. Amicrobial pustulosis of the folds associated with autoimmune disorders: systemic lupus erythematosus case series and first report on the association with autoimmune hepatitis.
    Méndez-Flores S; Charli-Joseph Y; Saeb-Lima M; Orozco-Topete R; Fernández Sánchez M
    Dermatology; 2013; 226(1):1-4. PubMed ID: 23467024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amicrobial pustulosis and systemic lupus erythematosus: a case].
    Saiag P; Blanc F; Marinho E; De la Blanchardière A; Leconte I; Cocheton JJ; Tulliez M
    Ann Dermatol Venereol; 1993; 120(11):779-81. PubMed ID: 8210111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amicrobial pustulosis and systemic lupus erythematosus].
    Oberlin P; Bagot M; Perrussel M; Leteinturier F; Wechsler J; Revuz J
    Ann Dermatol Venereol; 1991; 118(11):824-5. PubMed ID: 1789646
    [No Abstract]   [Full Text] [Related]  

  • 5. Deficiency of interleukin-1 receptor antagonist responsive to anakinra.
    Schnellbacher C; Ciocca G; Menendez R; Aksentijevich I; Goldbach-Mansky R; Duarte AM; Rivas-Chacon R
    Pediatr Dermatol; 2013; 30(6):758-60. PubMed ID: 22471702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amicrobial pustulosis of the folds: Where have we gone 25years after its original description?
    Schissler C; Velter C; Lipsker D
    Ann Dermatol Venereol; 2017 Mar; 144(3):169-175. PubMed ID: 28242094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-microbial pustulosis and systemic lupus erythematosus].
    López Estebaranz JL; Vanaclocha Sebastian F; Iglesias Díez L
    Ann Dermatol Venereol; 1996; 123(6-7):401-2. PubMed ID: 8959066
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of amicrobial pustulosis of the folds associated with neutrophilic gastrointestinal involvement in systemic lupus erythematosus.
    Kerl K; Masouyé I; Lesavre P; Saurat JH; Borradori L
    Dermatology; 2005; 211(4):356-9. PubMed ID: 16286747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amicrobial pustulosis of the folds. A cutaneous manifestation associated with connective tissue disease.
    Stefanidou MP; Kanavaros PE; Stefanaki KS; Tosca AD
    Dermatology; 1998; 197(4):394-6. PubMed ID: 9873184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amicrobial pustular dermatosis of the folds and Dapsone syndrome on treatment: a case report.
    Satta R; Bolognini S; Montesu MA; Cottoni F
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):501-2. PubMed ID: 18363916
    [No Abstract]   [Full Text] [Related]  

  • 11. A peculiar form of amicrobial pustulosis of the folds associated with systemic lupus erythematosus and other auto-immune diseases.
    Lagrange S; Chosidow O; Piette JC; Wechsler B; Godeau P; Frances C
    Lupus; 1997; 6(6):514-20. PubMed ID: 9256309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis.
    Ostendorf B; Iking-Konert C; Kurz K; Jung G; Sander O; Schneider M
    Ann Rheum Dis; 2005 Apr; 64(4):630-3. PubMed ID: 15345502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erosive osteoarthritis of the hand: clinical experience with anakinra.
    Bacconnier L; Jorgensen C; Fabre S
    Ann Rheum Dis; 2009 Jun; 68(6):1078-9. PubMed ID: 19435727
    [No Abstract]   [Full Text] [Related]  

  • 15. Schnitzler syndrome: response to anakinra in two cases and a review of the literature.
    Schuster C; Kränke B; Aberer E; Arbab E; Sturm G; Aberer W
    Int J Dermatol; 2009 Nov; 48(11):1190-4. PubMed ID: 20064173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation.
    Andrés M; Pascual E
    Ann Rheum Dis; 2013 Jan; 72(1):155. PubMed ID: 22887853
    [No Abstract]   [Full Text] [Related]  

  • 17. Case of anakinra as a steroid-sparing agent for gout inflammation.
    Gratton SB; Scalapino KJ; Fye KH
    Arthritis Rheum; 2009 Sep; 61(9):1268-70. PubMed ID: 19714614
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome - Successful use of PET- CT and Anakinra in its diagnosis and treatment.
    Tayer-Shifman OE; Ben-Chetrit E
    Mod Rheumatol; 2015; 25(6):954-7. PubMed ID: 24252009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
    Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
    Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).
    Vassilopoulos D; Lazaros G; Tsioufis C; Vasileiou P; Stefanadis C; Pectasides D
    Int J Cardiol; 2012 Sep; 160(1):66-8. PubMed ID: 22704870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.